What are Alnylam Pharmaceuticals's profit margins?

Alnylam Pharmaceuticals (ALNY) runs a 81.0% gross margin and a 17.5% operating margin, with a 11.7% net margin.

Where do Alnylam Pharmaceuticals's ratios come from?

Every ratio is computed from Alnylam Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Alnylam Pharmaceuticals ALNY Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Profitability
Gross margin	336%-11.5pp	347.5%+6.2pp	341.3%-5.3pp	346.6%+2.6pp
Operating margin	9.5%+30.8pp	-21.2%+150pp	-171.7%+143pp	-314.9%+114pp
Net margin	-11.1%+36.8pp	-47.9%+185pp	-232.7%+212pp	-444.4%+50.9pp
EBITDA margin	17.5%+28.5pp	-11%+146pp	-157.1%+139pp	-296.4%+107pp
Free cash flow margin	14%—	——	——	-273.9%+116pp
Returns
Return on assets	-4.4%+21.9pp	-26.3%+62.2pp	-88.6%+32.0pp	-120.6%-14.2pp
Efficiency
Asset turnover	2.7×+0.4×	2.3×+0.6×	1.7×+0.6×	1.1×+0.2×
Inventory turnover	24.3×+12.0×	12.3×+4.0×	8.4×+3.0×	5.4×+0.3×
Liquidity
Current ratio	11.1×-0.6×	11.7×-1.5×	13.2×-1.8×	15×-3.3×
Quick ratio	10.9×-0.5×	11.4×-1.3×	12.7×-1.8×	14.4×-3.3×
Cash ratio	3.9×+0.5×	3.4×-0.4×	3.8×-0.5×	4.3×0.0×
Leverage
Debt-to-equity	3.2×—	——	——	——
Debt-to-assets	0.2×0.0×	0.3×-0.1×	0.3×-0.4×	0.8×-0.1×
Interest coverage	2.1×+5.4×	-3.2×+13.9×	-17.2×+1.5×	-18.7×+4.5×
Per Share
Book value per share	$12.77+1,396%	-$0.99+88.3%	-$8.39-386%	$2.93-88.9%
Valuation
Market capitalization	$189.63B+64.6%	$115.22B+21.7%	$94.68B+4.6%	$90.51B+13.1%
Enterprise value	$185.43B+64.7%	$112.6B+21.5%	$92.66B+2.9%	$90.05B+12.0%
Price / sales	64.9×+12.0×	52.9×-14.0×	66.8×-28.6×	95.4×-17.8×
Price / book	573.2×—	——	——	——
EV / sales	63.4×+11.8×	51.7×-13.8×	65.5×-29.6×	95.1×-18.8×
Free cash flow yield	0.9%—	——	——	-11.8%+2.0pp
Earnings yield	-0.7%+3.2pp	-3.9%+9.1pp	-12.9%+6.0pp	-18.9%-1.4pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Alnylam Pharmaceuticals.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Alnylam Pharmaceuticals's profit margins?: Alnylam Pharmaceuticals (ALNY) runs a 81.0% gross margin and a 17.5% operating margin, with a 11.7% net margin.
Where do Alnylam Pharmaceuticals's ratios come from?: Every ratio is computed from Alnylam Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.